These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10562706)

  • 1. Vaccination by inducing oral tolerance?
    McSorley SJ; Garside P
    Immunol Today; 1999 Dec; 20(12):555-60. PubMed ID: 10562706
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA vaccines for parasitic infections.
    Kalinna BH
    Immunol Cell Biol; 1997 Aug; 75(4):370-5. PubMed ID: 9315480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis: current status of vaccine development.
    Sukumaran B; Madhubala R
    Curr Mol Med; 2004 Sep; 4(6):667-79. PubMed ID: 15357215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of oral tolerance.
    Garside P; Mowat AM
    Crit Rev Immunol; 1997; 17(2):119-37. PubMed ID: 9094449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity.
    Czerkinsky C; Sun JB; Lebens M; Li BL; Rask C; Lindblad M; Holmgren J
    Ann N Y Acad Sci; 1996 Feb; 778():185-93. PubMed ID: 8610972
    [No Abstract]   [Full Text] [Related]  

  • 7. Modern vaccines. Parasitic diseases.
    Playfair JH; Blackwell JM; Miller HR
    Lancet; 1990 May; 335(8700):1263-6. PubMed ID: 1971332
    [No Abstract]   [Full Text] [Related]  

  • 8. Dendritic cell vaccination in autoimmune disease.
    Gross CC; Wiendl H
    Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the molecular biology of trypanosomes and leishmaniae, and its impact on the development of methods for the diagnosis and vaccination of leishmaniasis and Chagas disease.
    O'Daly JA
    Biol Res; 1993; 26(1-2):219-24. PubMed ID: 7670534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of Th responses by oral tolerance.
    Garcia G; Weiner HL
    Curr Top Microbiol Immunol; 1999; 238():123-45. PubMed ID: 10087652
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral tolerance and its role in clinical disease.
    Spiekermann GM; Walker WA
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):237-55. PubMed ID: 11345170
    [No Abstract]   [Full Text] [Related]  

  • 12. [An immunologic method of producing antigens for the treatment and prevention of leishmaniasis].
    Vouldoukis I; Monjour L
    C R Acad Sci III; 1989; 308(5):129-34. PubMed ID: 2493318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB/C.
    Mortazavidehkordi N; Fallah A; Abdollahi A; Kia V; Khanahmad H; Najafabadi ZG; Hashemi N; Estiri B; Roudbari Z; Najafi A; Farjadfar A; Hejazi SH
    Parasitol Res; 2018 Jul; 117(7):2265-2273. PubMed ID: 29845415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M; Bahrami F; Niknam HM
    PLoS One; 2018; 13(9):e0204491. PubMed ID: 30248142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intestinal immune system and oral vaccination.
    Newby TJ; Stokes CR
    Vet Immunol Immunopathol; 1984 May; 6(1-2):67-105. PubMed ID: 6204436
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms and applications of oral tolerance].
    Marth T; Kelsall BL; Strober W; Zeitz M
    Z Gastroenterol; 1999 Feb; 37(2):165-85. PubMed ID: 10190250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
    Zanin FH; Coelho EA; Tavares CA; Marques-da-Silva EA; Silva Costa MM; Rezende SA; Gazzinelli RT; Fernandes AP
    Microbes Infect; 2007 Jul; 9(9):1070-7. PubMed ID: 17644455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bacterium's guide to orienteering in the intestinal lumen. Interview by Emma Louise Walton.
    Jang YS
    Microbes Infect; 2013 Nov; 15(13):845-8. PubMed ID: 24140556
    [No Abstract]   [Full Text] [Related]  

  • 19. New treatment avenues: oral tolerance--mechanisms and applicability to human diseases.
    Krause I; Blank M; Shoenfeld Y
    Isr Med Assoc J; 1999 Sep; 1(1):45-9. PubMed ID: 11370122
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
    J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.